Mesalamine Tablet, Delayed Release
Product Images NDC 84612-175

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 84612-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nuvaila Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label-mesalamine Dr Tablets (Label Mesalamine Dr Tablets)

This text is a label for delayed-release mesalamine tablets containing 1.2g of mesalamine. It provides information on the usual dosage, storage instructions, child-resistant packaging, and manufacturer details. The tablets are manufactured by Sun Pharmaceutical Industries Limited in India. The tablets are dispensed in a child-resistant package and should be stored between 20°C to 25°C. The label also includes the National Drug Code (NDC) and prescription instructions.*

FDA Label Image

Mesalamine Structural Formula (Mesalamine Structural Formula)

This text provides the molecular formula and weight of a compound, which is C7H7NO3 with a molecular weight of 153.14. This information is useful for identifying and studying the chemical compound.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.